Valspodar PK interactions were observed with paclitaxel but not L-DOX.
Pretreatment of d-cysteine- or l-cysteine-treated groups with indole-2-carboxylate reversed the gastroprotective effects of d-cysteine but not l-cysteine.
Western blotting studies indicated that Wy14643 and fenofibrate, but not rosiglitazone, increased the phosphorylation of endothelial nitric oxide synthase and AMPK; these effects were abolished by compound C but not L-NAME.
A dose of l-arginine (0.3 μg/rat), but not l-NAME, during expression of morphine-induced conditioned place preference produced an increase in locomotion compared with that in the control group.
On the other hand, NO production after ischemia was significantly reduced by 7-nitroindazole (25 mg/kg), l-NIO (20 mg/kg) + 7-nitroindazole (25 mg/kg) or carboxy-PTIO (1 mg/kg), but not l-NIO (20 mg/kg).
This NO increase during ischemia was significantly reduced by l-NIO (20 mg/kg) + 7-nitroindazole (25 mg/kg) or carboxy-PTIO (1 mg/kg), but not l-NIO (20 mg/kg) or 7-nitroindazole (25 mg/kg).
Further, functional studies of isolated mitochondria indicate that H-PLL, but not L-PLL, can directly induce Cyt c release, membrane depolarization, and a progressive decline in the rate of uncoupled respiration.
In MCF-7 breast cancer cells, with little constitutively active Akt, d-3-deoxy-diC8PI (but not l-compounds) decreases viability concomitant with increased cleavage of PARP and caspase 9, indicative of apoptosis.
When l-arginine or l-NAME at 0.3 3.0 μg/rat was administered 1 min before conditioned place preference testing, l-arginine but not l-NAME caused an increase in the expression of morphine-induced conditioned place preference, the effect that was blocked by l-NAME preadministration.
HepG2 and HuH-7 effectively induced cytokine production of both two GPC3 CAR-T cells, but not L-02 cells and the groups containing mock T cells.
